The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor

Cell Growth and Differentiation

Volumn 8, Issue 4, 1997, Pages 471-479

  Taraboletti, Giulia ^a   Belotti, Dorina ^a   Borsotti, Patrizia ^a   Vergani, Veronica ^a   Rusnati, Marco ^b   Presta, Marco ^b   Giavazzi, Raffaella ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BINDING SITES; CATTLE; CELL ADHESION MOLECULES; CELL DIVISION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HEPARIN; MEMBRANE GLYCOPROTEINS; MOLECULAR WEIGHT; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PROTEIN BINDING; THROMBOSPONDINS;

ANIMALIA;

EID: 0030964285     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bornstein, P., and Sage, E. H. Thrombospondins. Methods Enzymol., 245: 62-85, 1994.
2. Frazier, W. A. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J. Cell Biol., 105: 625-632, 1987.
3. Mosher, D. F. Physiology of thrombospondin. Annu. Rev. Med., 41: 85-97, 1990.
4. Kramer, R. H., Fuh, G. M., Bensch, K. G., and Karasek, M. A. Synthesis of extracellular matrix glycoprotein by cultured microvascular endothelial cells isolated from the dermis of neonatal and adult skin. J. Cell. Physiol., 123: 1-9, 1985.
5. Mumby, S. M., Abbott-Brown, D., Raugi, G. J., and Bornstein, P. Regulation of thrombospondin secretion by cells in culture. J. Cell. Physiol., 120: 280-288, 1984.
6. O'Shea, K. S., and Dixit, V. M. Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J. Cell Biol., 107: 2737-2748, 1988.
7. Raugi, G. J., Mullen, J. S., Bark, D. H., Okada, T., and Mayberg, M. R. Thrombospondin deposition in rat carotid artery injury. Am. J. Pathol., 137: 179-185, 1990.
8. Raugi, G. J., Olerud, J. E., and Gown, A. M. Thrombospondin in early human wound tissue. J. Invest. Dermatol., 89: 551-554, 1987.
9. Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA, 87: 6624-6628, 1990.
10. Rastinejad, F., Polverini, P. J., and Bouck, N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56: 345-355, 1989.
11. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
12. Taraboletti, G., Roberts, D., Liotta, L. A., and Giavazzi, R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol., 111: 765-772, 1990.
13. Bagavandoss, P., and Wilks, J. W. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun., 170: 867-872, 1990.
14. Iruela-Arispe, M. L., Bornstein, P., and Sage, H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA, 88: 5026-5030, 1991.
15. DiPietro, L. A., Nebgen, D. R., and Polverini, P. J. Down-regulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J. Vasc. Res., 31: 178-185, 1994.
16. Weinstat-Saslow, D. L., Zabrenetzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., and Steeg, P. S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res., 54: 6504-6511, 1994.
17. Nickoloff, B. J., Mitra, R. S., Varani, J., Dixit, V. M., and Polverini, P. J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol., 144: 820-828, 1994.
18. Sheibani, N., and Frazier, W. A. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc. Natl. Acad. Sci. USA, 92: 6788-6792, 1995.
19. BenEzra, D., Griffin, B. W., Maftzir, G., and Aharonov, O. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest. Ophthalmol. Visual Sci., 34: 3601-3608, 1993.
20. Nicosia, R. F., and Tuszynski, G. P. Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol., 124: 183-193, 1994.
21. DiPietro, L. A., and Polverini, P. J. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am. J. Pathol., 143: 678-684, 1993.
22. Bornstein, P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol., 130: 503-506, 1995.
23. Taraboletti, G., Belotti, D., and Giavazzi, R. Thrombospondin modulates basic fibroblast growth factor activities on endothelial cells. In: R. Steiner, P. B. Weisz, and R. Langer (eds.), Angiogenesis: Key Principles -Science - Technology - Medicine, pp. 210-213. Basel, Switzerland: Birghauser Verlag, 1992.
24. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. P. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol., 122: 497-511, 1993.
25. Vogel, T., Guo, N., Krutzsch, H. C., Blake, D. A., Hartman, J., Mendelovitz, S., Panet, A., and Roberts, D. D. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J. Cell. Biochem., 53: 74-84, 1993.
26. Galvin, N. J., Dixit, V. M., O'Rourke, K. M., Santoro, S. A., Grant, G. A., and Frazier, W. A. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J. Cell Biol., 101: 1434-1441, 1985.
27. Lawler, J. The structural and functional properties of thrombospondin. Blood, 67: 1197-1209, 1986.
28. Slayter, H. S. Secretion of thrombospondin from human blood platelets. Methods Enzymol., 169: 251-269, 1992.
29. Moscatelli, D. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J. Cell Biol., 107: 753-759, 1988.
30. Müller, G., Behrens, J., Nussbaumer, U., Böhlen, P., and Birchmeier, W. Inhibitory action of transforming growth factor β on endothelial cells. Proc. Natl. Acad. Sci. USA, 84: 5600-5604, 1987.
31. Murphy-Ullrich, J. E., Schultz-Cherry, S., and Höök, M. Transforming growth factor-β complexes with thrombospondin. Mol. Biol. Cell, 3: 181-188, 1992.
32. Sun, X., and Mosher, D. F. Contamination of thrombospondin with vitronectin. Blood, 76: 1666-1667, 1990.
33. Hogg, P. J. Thrombospondin 1 as an enzyme inhibitor. Thromb. Haemostasis, 72: 787-792, 1994.
34. Schultz-Cherry, S., Ribeiro, S., Gentry, L., and Murphy-Ullrich, J. E. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J. Biol. Chem., 269: 26775-26782, 1994.
35. Lamszus, K., Joseph, A., Jin, L., Yao, Y., Chowdhury, S., Fuchs, A., Polverini, P. J., Goldberg, I. D., and Rosen, E. M. Scatter factor binds to thrombospondin and other extracellular matrix components. Am. J. Pathol., 149: 805-819, 1996.
36. Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Krutzsch, H. C., Roberts, D. D., and Murphy-Ullrich, J. E. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J. Biol. Chem., 270: 7304-7310, 1995.
37. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64: 841-848, 1991.
38. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol., 12: 240-247, 1992.
39. Rusnati, M., Urbinati, C., and Presta, M. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J. Cell. Physiol., 154: 152-161, 1993.
40. Moscatelli, D. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. J. Biol. Chem., 267: 25803-25809, 1992.
41. Guo, N., Krutzsch, H. C., Negre, E., Zabrenetzky, V. S., and Roberts, D. D. Heparin-binding peptides from the type I repeats of thrombospondin. J. Biol. Chem., 267: 19349-19355, 1992.
42. Haverstick, D. M., Dixit, V. M., Grant, G. A., Frazier, W. A., and Santoro, S. A. Localization of the hemagglutinating activity of platelet thrombospondin to a 140,000-Dalton thermolitic fragment. Biochemistry, 23: 5597-5603, 1984.
43. Kosfeld, M. D., Pavlopoulos, T. V., and Frazier, W. A. Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli. J. Biol. Chem., 266: 24257-24259, 1991.
44. Neufeld, G., and Gospodarowicz, D. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem., 260: 13860-13868, 1985.
45. Munson, P. J. Ligand: a computerized analysis of ligand binding data. Methods Enzymol., 92: 542-576, 1983.